Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat
Not Applicable
- Conditions
- Laser Assisted Liposuction
- Interventions
- Device: LipoLife system
- Registration Number
- NCT05016674
- Lead Sponsor
- Alma Lasers
- Brief Summary
Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
- Subjects scheduled to undergo abdominal w/wo flanks laser-assisted liposuction surgery and are willing to donate the harvested adipose tissue for the study assessment.
- Between 18 and 70 years of age.
- Estimated fat harvesting of at least 300 milliliters.
- Provided written Informed Consent.
Exclusion Criteria
- Pregnant or intending to become pregnant during the course of study.
- Current smoker.
- Presence of known malignancy.
- Active infection in the treatment area.
- History of autoimmune disorder (e.g., Systemic Lupus Erythematosus [SLE]).
- History of connective, metabolic, or atrophic skin disease.
- History of keloid scarring.
- Chronic use (>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days before enrollment.
- Subjects with immune system diseases.
- Any other reason that in the opinion of the investigator, prevents the subject from participating in the study or compromises the subject safety.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Laser-assisted liposuction LipoLife system Laser-Assisted Liposuction with the LipoLife system.
- Primary Outcome Measures
Name Time Method Average adipose cell cluster size 6 months Assessment of adipose cell cluster size by microscope
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
William Jason Martin, MD
🇺🇸Denver, Colorado, United States